Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Angiogenesis, the formation of new blood vessels, is vital in development and disease, including cancer and macular degeneration.
• Vascular Endothelial Growth Factors (VEGFs) and their receptors (VEGFRs) are key regulators of angiogenesis.
• VEGFR-3, typically found on lymphatic endothelium, is also upregulated in pathological angiogenesis.

Purpose of the Study:

• To investigate the role of VEGFR-3 in angiogenesis.
• To evaluate VEGFR-3 as a therapeutic target for anti-angiogenic strategies.

Main Methods:

• Utilized mouse models of angiogenesis.
• Employed genetic targeting and monoclonal antibodies to block VEGFR-3 signaling.
• Investigated the interplay between VEGFR-3, VEGFR-2, and Notch signaling pathways.

Main Results:

• VEGFR-3 is highly expressed in angiogenic sprouts.
• Blocking VEGFR-3 signaling reduced sprouting, vascular density, and endothelial cell proliferation.
• VEGFR-3 stimulation enhanced VEGF-induced angiogenesis and sustained it against VEGFR-2 inhibitors.
• Combined VEGFR-2 and VEGFR-3 blockade showed additive inhibition of angiogenesis and tumor growth.
• Disruption of Notch signaling led to increased VEGFR-3 expression and sprouting, which was blocked by VEGFR-3 inhibition.

Conclusions:

• VEGFR-3 acts as a regulator of vascular network formation.
• Targeting VEGFR-3 may improve the efficacy of anti-angiogenic therapies, especially for resistant vasculature.